ISAM - The International Society for Aerosols in Medicine
This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Facilitated by the European Respiratory Society (ERS)
When: 16 December, 2021 | Online, 18:00–19:00 CET
Chairs: Ms. Andreja Šajnić (Zagreb, Croatia)
Discussants:
Prof. Marko Jakopović (Zagreb, Croatia),
Ms. Anita Breški (Zagreb, Croatia),
Mr. Ivica Belina (Zagreb, Croatia)
Fees: Free for ERS members and non-members
Novelties in past few years in treatment lung cancer have expanded, and by entering molecular testing as diagnostic tool open possibilities for lung cancer patients with targeted therapies that provides better quality of life and
longer survival.
Educational aims
Discussion will take place about importance of diagnostic and show recent improvements in targeted therapies in lung cancer patients.
The goal of this webinar is to get acquainted with molecular testing in diagnostic procedure in lung cancer patients.
This webinar will emphasize proper sample collecting and deliver to the laboratory.
Participants will base on the acquired knowledge that proper sampling in diagnostic procedure in lung cancer patients gets shorter and efficient.
Format
Panel discussion
Lectures will be provided with examples and new studies in this field
Case presentations from clinical field
Quizzes, multiple choice questions
Patient’s experience: results from on-line survey
Topics/Programme
Novelties in target therapies
Multidisciplinary approach integrated in diagnostic pathway